Clinical trial
INJECT: A Pilot Study of Intra-tumoral Injections in Metastatic Urological Cancers
NCT03071328 is registered in ClinicalTrials.gov with Duke University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- INJECT: A Pilot Study of Intra-tumoral Injections in Metastatic Urological Cancers
- Lead sponsor
- Duke University
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 8, 2018
- Completion date
- April 30, 2021
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
metastatic castration-resistant prostate cancer (mcrpc), metastatic renal cell carcinoma, metastatic urothelial carcinoma